Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.

Thorac Cancer · 2025 · PMC11954129 · PMID 40156491

Europe PMC DOI

hedged sentence

0.1440

closest p · 2.9× alpha

0.1440

boldest claim

The sentences

did not reach statistical significancep = 0.144not close (p > 0.1)

However, it is important to note that the observed difference did not reach statistical significance ( p = 0.144, Figure 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.